aTyr Pharma (LIFE) Misses Q4 EPS by 3c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Buy the pullback in chip stocks, JPM's Matejka says
• Radoff-Jumana Group calls for Genesco CEO to lose board chair role